Skip to content
Monday, 16 November 2026
Inspire.News

Unveiling truth, one story at a time

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

Full story

Continue reading this story on CNBC, the publisher that reported it.

Read the full story at CNBC ↗

AI tools

Written by AI from the article text. It can make mistakes; check the original story.

Topics in this story

More from Business

See all